Clinical, Translational and Outcomes Research Award (CTORA)

Application Deadline
Award Amount
$200,000 ($100,000/year)
Award Term
Two years
Award Type
Project-Based
Clinical / Translational / Outcomes Research
Career Level
Junior Faculty

View the 2024 Request for Applications [PDF].

Overview

The purpose of these awards is to foster career development for individuals performing clinical research, translational research, or outcomes research in a liver-related area and who have shown commitment to excellence at an early stage of their research study.  The award is intended to ensure that a significant portion of young investigators’ time is protected for research, with an overall objective of enabling young investigators to develop independent and productive research careers in liver disease.

  • Applications in health disparities-related research are encouraged.
  • One award per year will be prioritized for meritorious transplant-related research in memory of the University of Michigan Transplant Team. 

Notice of Special Interest

Additional dedicated funding to advance research activities in autoimmune hepatitis is available for the 2024 Awards cycle. Applications in autoimmune hepatitis are encouraged in all early to mid-career research award categories and the Pilot and Autoimmune Exploratory Research Award categories.

  • Eligibility
  • Award Details
  • Selection Criteria
  • How to Apply
  • Application Resources
  • CMS Open Payments Disclaimer

Eligibility

In order to be eligible for this award, the applicant must adhere to the following guidelines:

  1. The applicant must:
    • Be within the first five years of their first faculty appointment (including prior appointments in universities outside of North America) at the start of the award (faculty appointment starting no earlier than July 1, 2019).
      • If the applicant does not have a faculty appointment at the time of application, the letter of commitment from their department chair must explicitly confirm that the applicant will have a faculty appointment (i) no later than the Award start date and (ii) for the full award cycle.
    • Be a member of the American Association for the Study of Liver Diseases (AASLD) at the time of award application and maintain active membership for the duration of the award period
    • Be able to devote at least 50% effort to the research project on which this application is based.
    • Be sponsored by a public or private non-profit institution accredited in the United States, Canada or Mexico engaged in health care and health-related research. Individuals employed at the NIH, FDA, and CDC are not eligible to apply.
    • Have a research mentor or co-mentor who is an AASLD member in good standing at the time of application and for the duration of the award period.
    • Not hold/have held any other similar award that is intended to primarily support the salary of early career investigators (including but not limited to NIH R, P or most K level grants, or similar career development awards from federal or non-federal sources. See eligibility list for more common programs).
  2. The proposed project must: 
    • Be clinical (direct contact with patients, clinical trials), translational (investigation using patient samples), or outcomes-based (epidemiological studies, patient-centered outcomes, or health services) research. 
    • Be conducted at the sponsoring institution within the United States, Canada or Mexico.
  3. Application limits:
    • A single sponsoring institution may submit up to two applications per distinct department within each institutional training site, but only one applicant may be funded per department within each institution for this award category.
    • Applicants may only apply for one AASLD Foundation award per calendar year.   

QUESTIONS

Questions? Contact awards@aasld.org.

Return to Current Funding Opportunities

 

ACKNOWLEDGEMENTS

The 2024 Clinical, Translational, and Outcomes Research Award in Liver Diseases program is made possible through independent grants and unrestricted donations from AASLD and donors to the AASLD Foundation.